Literature DB >> 23944316

Sofosbuvir for previously untreated chronic hepatitis C infection.

Eric Lawitz, Edward J Gane.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23944316     DOI: 10.1056/NEJMc1307641

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  42 in total

1.  Re-treatment of chronic hepatitis C virus genotype 1 infection after relapse: an open-label pilot study.

Authors:  Anu Osinusi; Anita Kohli; Miriam M Marti; Amy Nelson; Xiaozhen Zhang; Eric G Meissner; Rachel Silk; Kerry Townsend; Phillip S Pang; G Mani Subramanian; John G McHutchison; Anthony S Fauci; Henry Masur; Shyam Kottilil
Journal:  Ann Intern Med       Date:  2014-11-04       Impact factor: 25.391

Review 2.  Hepatitis C Virus-Genotype 3: Update on Current and Emergent Therapeutic Interventions.

Authors:  Steven W Johnson; Dorothea K Thompson; Brianne Raccor
Journal:  Curr Infect Dis Rep       Date:  2017-06       Impact factor: 3.725

3.  Clinical Monitoring of Chronic Hepatitis C Based on its Natural History and Therapy.

Authors:  Douglas L Nguyen; Ke-Qin Hu
Journal:  N Am J Med Sci (Boston)       Date:  2014

Review 4.  Hepatitis C.

Authors:  Daniel P Webster; Paul Klenerman; Geoffrey M Dusheiko
Journal:  Lancet       Date:  2015-02-14       Impact factor: 79.321

5.  High incidence of the hepatitis C virus recombinant 2k/1b in Georgia: Recommendations for testing and treatment.

Authors:  Marine Karchava; Jesper Waldenström; Monica Parker; Renee Hallack; Lali Sharvadze; Lana Gatserelia; Nikoloz Chkhartishvili; Natia Dvali; Lela Dzigua; Ekaterine Dolmazashvili; Helene Norder; Tengiz Tsertsvadze
Journal:  Hepatol Res       Date:  2015-03-24       Impact factor: 4.288

6.  HIV Infection Status as a Predictor of Hepatitis C Virus RNA Testing in Primary Care.

Authors:  Anthony K Yartel; Rebecca L Morgan; David B Rein; Kimberly Ann Brown; Natalie B Kil; Omar I Massoud; Michael B Fallon; Bryce D Smith
Journal:  Am J Prev Med       Date:  2015-04-18       Impact factor: 5.043

7.  CROI 2015: Highlights of Viral Hepatitis Therapy.

Authors:  Anne F Luetkemeyer; David L Wyles
Journal:  Top Antivir Med       Date:  2015 Mar-Apr

8.  PharmGKB summary: peginterferon-α pathway.

Authors:  Scott R Shuldiner; Li Gong; Andrew J Muir; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2015-09       Impact factor: 2.089

Review 9.  Enhancing our understanding of current therapies for hepatitis C virus (HCV).

Authors:  Neliswa A Gogela; Ming V Lin; Jessica L Wisocky; Raymond T Chung
Journal:  Curr HIV/AIDS Rep       Date:  2015-03       Impact factor: 5.071

10.  A Conserved Inhibitory Mechanism of a Lycorine Derivative against Enterovirus and Hepatitis C Virus.

Authors:  Yu Guo; Yaxin Wang; Lin Cao; Peng Wang; Jie Qing; Qizhen Zheng; Luqing Shang; Zheng Yin; Yuna Sun
Journal:  Antimicrob Agents Chemother       Date:  2015-11-23       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.